Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Year Ending	Current	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Market Capitalization	94	98	172	143	49	78
Market Cap Growth	-24.91%	-42.82%	20.19%	191.52%	-37.33%	3.28%
Enterprise Value	71	75	142	107	40	72
PE Ratio	-	-10.01	-12.63	-11.03	-4.89	-6.71
PS Ratio	-	467.53	-	279.02	-	312.81
PB Ratio	3.98	4.03	5.91	4.03	5.59	14.94
P/FCF Ratio	-13.20	-15.81	-26.45	-29.14	-7.92	-15.90
P/OCF Ratio	-13.20	-15.81	-26.45	-28.93	-7.94	-16.49
EV/Sales Ratio	-	354.82	-	209.75	-	289.44
EV/EBITDA Ratio	-6.21	-7.63	-10.50	-8.33	-4.03	-6.24
EV/EBIT Ratio	-6.18	-7.59	-10.46	-8.29	-3.99	-6.21
EV/FCF Ratio	-9.98	-12.00	-21.91	-21.90	-6.46	-14.72
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	-
Debt / EBITDA Ratio	-0.01	-0.02	-0.02	-0.02	-0.01	-
Debt / FCF Ratio	-0.02	-0.03	-0.03	-0.05	-0.01	-
Quick Ratio	13.95	11.89	14.60	28.13	7.62	3.99
Current Ratio	14.41	12.50	14.83	28.35	7.88	4.11
Asset Turnover	0	0.01	0	0.02	0	0.04
Return on Equity (ROE)	-47.30%	-37.60%	-42.90%	-42.10%	-142.60%	-202.10%
Return on Assets (ROA)	-45.50%	-36.30%	-41.50%	-41.00%	-129.70%	-170.20%
Return on Capital (ROIC)	-54.56%	-44.92%	-47.41%	-36.80%	-113.18%	-227.11%
Earnings Yield	-12.32%	-9.99%	-7.92%	-9.07%	-20.44%	-14.89%
FCF Yield	-7.63%	-6.32%	-3.78%	-3.43%	-12.63%	-6.29%
Buyback Yield / Dilution	-3.18%	-2.00%	-6.28%	-28.57%	-12.33%	-12.29%
Total Shareholder Return	-3.18%	-2.00%	-6.28%	-28.57%	-12.33%	-12.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).